Charles River Laboratories International, Inc. Stock BOERSE MUENCHEN
Equities
RV6
US1598641074
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
202.5 EUR | 0.00% | -5.99% | -5.59% |
Sales 2024 * | 4.22B 3.89B | Sales 2025 * | 4.53B 4.18B | Capitalization | 11.28B 10.4B |
---|---|---|---|---|---|
Net income 2024 * | 406M 374M | Net income 2025 * | 513M 473M | EV / Sales 2024 * | 3.13 x |
Net Debt 2024 * | 1.94B 1.79B | Net Debt 2025 * | 1.46B 1.34B | EV / Sales 2025 * | 2.81 x |
P/E ratio 2024 * |
27.7
x | P/E ratio 2025 * |
22.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Charles River Laboratories International, Inc.
1 week | -5.99% | ||
Current month | -5.29% | ||
1 month | -6.68% | ||
3 months | -10.99% | ||
6 months | +12.50% | ||
Current year | -5.59% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 02-12-31 |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Robert Bertolini
BRD | Director/Board Member | 61 | 11-01-24 |
Date | Price | Change |
---|---|---|
24-05-23 | 202.5 | 0.00% |
24-05-22 | 202.5 | 0.00% |
24-05-21 | 202.5 | -0.83% |
24-05-20 | 204.2 | +0.15% |
24-05-17 | 203.9 | -1.83% |
Real-time BOERSE MUENCHEN, May 23, 2024 at 07:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.77% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- CRL Stock
- RV6 Stock